Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated with Rosacea: Pooled Analysis of the two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials
Stein-Gold, L.; Kircik, L.; Draelos, Z.D.; Werschler, P.; DuBois, J.; Lain, E.; Baumann, L.; Goldberg, D.; Kaufman, J.; Tanghetti, E.; Ahluwalia, G.; Alvandi, N.; Weng, E.; Berk, D.
Journal of Drugs in Dermatology Jdd 17(11): 1201-1208
2018
ISSN/ISBN: 1545-9616 PMID: 30500142 Document Number: 17655
Background: Rosacea is a chronic dermatologic condition with limited treatment options.
Document emailed within 1 workday
Related Documents
Baumann, L.; Goldberg, D.J.; Stein Gold, L.; Tanghetti, E.A.; Lain, E.; Kaufman, J.; Weng, E.; Berk, D.R.; Ahluwalia, G. 2018: Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated with Rosacea: Findings from the Second REVEAL Trial Journal of Drugs in Dermatology: Jdd 17(3): 290-298Kircik, L.H.; DuBois, J.; Draelos, Z.D.; Werschler, P.; Grande, K.; Cook-Bolden, F.E.; Weng, E.; Berk, D.R.; Ahluwalia, G. 2018: Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated with Rosacea: Findings from the first REVEAL Trial Journal of Drugs in Dermatology: Jdd 17(1): 97-105
Garcia, C.; Birch, M. 2018: Oxymetazoline Hydrochloride 1% Cream (Rhofade) for Persistent Facial Erythema Associated with Rosacea American Family Physician 97(12): 808-810
Tanghetti, E.A.; Dover, J.S.; Goldberg, D.J.; Dhawan, S.S.; Luo, L.; Berk, D.R.; Ahluwalia, G.; Alvandi, N. 2018: Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the first day of Treatment with Oxymetazoline Cream 1.0 Journal of Drugs in Dermatology: Jdd 17(6): 621-626
Fowler, J.; Jackson, M.; Moore, A.; Jarratt, M.; Jones, T.; Meadows, K.; Steinhoff, M.; Rudisill, D.; Leoni, M. 2013: Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies Journal of Drugs in Dermatology: Jdd 12(6): 650-656
Mazzetti, A.; Moro, L.; Gerloni, M.; Cartwright, M. 2019: A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects with Facial Acne Journal of Drugs in Dermatology: Jdd 18(6): 570
Gold, L.S.; Papp, K.; Lynde, C.; Lain, E.; Gooderham, M.; Johnson, S.; Kerrouche, N. 2017: Treatment of Rosacea with Concomitant use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: a Randomized, Vehicle-controlled Study Journal of Drugs in Dermatology: Jdd 16(9): 909-916
Hebert, A.A.; Albareda, N.; Rosen, T.; Torrelo, A.; Grimalt, R.; Rosenberg, N.; Zsolt, I.; Masramon, X. 2018: Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Pooled Analysis of Phase 3 Clinical Trials Journal of Drugs in Dermatology: Jdd 17(10): 1051-1057
Lalezari, J.; Campion, K.; Keene, O.; Silagy, C. 2001: Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials Archives of Internal Medicine 161(2): 212-217
Gemzell-Danielsson, K.; Kardos, L.; von Hertzen, H. 2015: Impact of bodyweight/body mass index on the effectiveness of emergency contraception with levonorgestrel: a pooled-analysis of three randomized controlled trials Current Medical Research and Opinion 31(12): 2241-2248
Moore, A.; Kempers, S.; Murakawa, G.; Weiss, J.; Tauscher, A.; Swinyer, L.; Liu, H.; Leoni, M. 2014: Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study Journal of Drugs in Dermatology: Jdd 13(1): 56-61
Salk, R.S.; Grogan, K.A.; Chang, T.J. 2006: Topical 5% 5-fluorouracil cream in the treatment of plantar warts: a prospective, randomized, and controlled clinical study Journal of Drugs in Dermatology: Jdd 5(5): 418-424
Lebwohl, M.G..; Sugarman, J.L..; Stein Gold, L.; Lin, T.; Israel, R. 2019: Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of two Phase IIi Randomized Controlled Trials Journal of Drugs in Dermatology: Jdd 18(10): 1012-1018
Stein Gold, L.F.; Parish, L.C.; Vlahovic, T.; Plaum, S.; Kircik, L.; Fleischer, A.B.; Verma, A.; Olayinka, B.; Hardas, B. 2013: Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials Journal of Drugs in Dermatology: Jdd 12(8): 911-918
Shamsudin, N.; Fleischer, A.B. 2010: Vehicle or placebo? Investigators use incorrect terminology in randomized controlled trials half of the time: a systematic review of randomized controlled trials published in three major dermatology journals Journal of Drugs in Dermatology: Jdd 9(10): 1221-1226
Austin, E.; Nguyen, J.K..; Jagdeo, J. 2019: Topical Treatments for Melasma: a Systematic Review of Randomized Controlled Trials Journal of Drugs in Dermatology: Jdd 18(11)
Draelos, Z.D.; Rodriguez, D.A.; Kempers, S.E.; Bruce, S.; Peredo, M.I.; Downie, J.; Chang-Lin, J.-E.; Berk, D.R.; Ruan, S.; Kaoukhov, A. 2017: Treatment Response with Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from two Randomized, Double-Blind Stu Journal of Drugs in Dermatology: Jdd 16(6): 591-598
Brache, V.; Cochon, L.; Deniaud, Mëva.; Croxatto, H.B. 2013: Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens Contraception 88(5): 611-618
Tirlapur, V.G.; Rice-Oxley, J.M. 1981: Facial erythema and telangiectasia with synalar cream British Journal of Clinical Practice 35(7-8): 275-276
Shalita, A.; Miller, B.; Menter, A.; Abramovits, W.; Loven, K.; Kakita, L. 2005: Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study Journal of Drugs in Dermatology: Jdd 4(2): 153-158